Unichem Pharma USA has voluntarily recalled their 5mg Buspirone tablets due to a discrepancy in quality during a 12-month stability test. No reports of adverse events have been received, but the company stresses its commitment to patient safety and product quality.

ICRA maintains a high rating ('A') for Unichem Labs' bank loans worth INR 180 crores, signifying the company's stable credit standing and no changes in its creditworthiness.